Validation of the i-Tracker Drug and Total Anti-Drug Antibody CLIA Assays on IDS-iSYS for Therapeutic Drug Monitoring in Adalimumab- and Infliximab-Treated Patients
- DOI
- 10.3390/diagnostics15192447
- Published
- 2025-09-25
- Container
- Diagnostics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/diagnostics15192447,
title = {Validation of the i-Tracker Drug and Total Anti-Drug Antibody CLIA Assays on IDS-iSYS for Therapeutic Drug Monitoring in Adalimumab- and Infliximab-Treated Patients},
author = {Akpedje Serena Dossou and Serena Kang and Tahira Kalhoro and Eduardo Castro-Echeverry and Nathan C. Horton},
year = {2025},
journal = {Diagnostics},
doi = {10.3390/diagnostics15192447},
url = {https://doi.org/10.3390/diagnostics15192447}
}RIS
TY - JOUR TI - Validation of the i-Tracker Drug and Total Anti-Drug Antibody CLIA Assays on IDS-iSYS for Therapeutic Drug Monitoring in Adalimumab- and Infliximab-Treated Patients AU - Akpedje Serena Dossou AU - Serena Kang AU - Tahira Kalhoro AU - Eduardo Castro-Echeverry AU - Nathan C. Horton PY - 2025 JO - Diagnostics DO - 10.3390/diagnostics15192447 UR - https://doi.org/10.3390/diagnostics15192447 ER -
APA
Dossou, A. S., Kang, S., Kalhoro, T., Castro-Echeverry, E., & Horton, N. C. (2025). Validation of the i-Tracker Drug and Total Anti-Drug Antibody CLIA Assays on IDS-iSYS for Therapeutic Drug Monitoring in Adalimumab- and Infliximab-Treated Patients. Diagnostics. https://doi.org/10.3390/diagnostics15192447
Source records
- crossref · retrieved 2026-09-25T08:24:59.399Z